CION Ameerpet
Clinical Trials & Access
Can You Leave a Clinical Trial Once You Have Started? — Yes, at Any Time, Without Losing Standard Care
Yes. Taking part in a clinical trial is voluntary from the first day to the last. You may withdraw at any point, for any reason, and you do not have to justify it. Under India’s New Drugs and Clinical Trials Rules, 2019, withdrawal must not cost you the treatment you were otherwise entitled to.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026
- Withdrawal is a right, not a request — You do not need the sponsor’s permission and you do not need to give a reason. Consent can be taken back at any point, and the study team must record it.
- Your standard treatment continues — Leaving a study does not remove your routine care at that hospital, and your own oncologist keeps treating you. Ask for the next plan in writing before you stop.
- You choose how far you withdraw — Stopping the study drug and leaving safety follow-up are separate decisions. Many people stop the treatment and stay in follow-up, which is what protects them.
- Information, not recruitment — Nothing on this page is an offer of a place on any study, no enrolment can be assured by anyone, and no benefit is claimed for any investigational treatment.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
The direct answer
Can You Leave a Clinical Trial Once You Have Started?
Yes. Taking part is voluntary at every stage, and you may withdraw at any time without giving a reason. Consent is not a contract that binds you to finish. Your standard treatment, your own oncologist and your care at that hospital do not depend on staying in the study.
The fear of being trapped is the single most common reason families refuse a trial conversation before it starts. It is worth naming, because it is the one fear the rules were written to remove. Informed consent in India is defined as a process rather than a signature, and the right to walk away is part of the process, not an exception to it. The consent document you sign has to state that participation is voluntary and that you may withdraw at any time — and it has to state it in a language you understand.
What confuses people is that “leaving” is not one thing. Stopping the study drug, stopping the follow-up visits and being taken off study by the doctor are different events with different consequences. Knowing which one is on the table changes the conversation from a panic to a decision.
| How participation ends | Who decides | What usually continues |
|---|---|---|
| You stop the study drug but stay in follow-up | You | Scheduled safety visits and monitoring continue; data already collected is kept; your treatment moves to a standard plan |
| You withdraw from the study completely | You | Study visits stop; an end-of-study safety check should still be offered; routine care at that hospital continues |
| A dose is held or delayed for toxicity | You and the study team | This is not withdrawal — the protocol allows it, and treatment may restart once the side effect settles |
| The investigator takes you off study treatment | The study doctor, under the protocol | Usually where continuing would be unsafe or the disease has progressed; the reason must be explained and a standard plan offered |
| The sponsor, ethics committee or regulator stops the study | Sponsor / ethics committee / CDSCO | Everyone comes off study; participants must be informed and moved to an alternative plan |
The rows above describe how cancer studies are commonly structured and are general and indicative, as of August 2026. They do not describe the specific study you are on. Your own protocol and participant information sheet set out the exact terms, and you are entitled to a copy of both.
Did you know?
Under India’s New Drugs and Clinical Trials Rules, 2019 and the ICMR National Ethical Guidelines for Biomedical and Health Research Involving Human Participants, a participant may withdraw from a study at any time, without loss of benefits to which they are otherwise entitled. The consent document must say this in a language the participant understands, an ethics committee reviews that document before the study opens, and for several categories of trial the consent process itself must be audio-visually recorded. Withdrawal is something the study team is required to record — not something it is entitled to resist.
Your ongoing treatment
Does Leaving a Trial Affect Your Future Cancer Treatment?
It should not. You keep the standard treatment your diagnosis calls for, and the hospital keeps treating you. Ethics guidance is explicit that withdrawal must not cost you care you were otherwise entitled to. What changes is the schedule — study visits stop and a routine plan takes their place.
What continues, and what you should ask for
- Your own oncologist continues — the treating relationship is not owned by the study, and it does not end when your participation does.
- Routine care at that hospital continues — appointments, admissions and day-care slots run on the normal pathway, not a reduced one.
- Ask for the next plan in writing — what treatment follows, when it starts, where it is given. A dated plan is what stops a gap opening.
- An injury related to the trial is not erased by leaving — the sponsor’s obligations under the New Drugs and Clinical Trials Rules, 2019 relate to what happened while you were a participant. Have it recorded.
- Follow-up may still be requested — teams often ask to keep checking safety after the drug stops. You can agree to that and still stop treatment.
- Rejoining is not automatic — no place on any study can be assured by anyone, so treat withdrawal as a real decision rather than a pause.
If anyone suggests that leaving a study will cost you your treatment, your bed or your doctor, that is not how a properly conducted trial works. Raise it with the principal investigator, and with the ethics committee whose contact details are printed on your consent document.
Records and samples
What Happens to Your Data and Samples If You Withdraw?
Information collected before you withdraw is normally kept and analysed, and the consent document usually says so in advance. What happens next is yours to decide. You can stop further data being collected, and you can often ask for stored blood or tissue to be destroyed.
- Data already collected normally stays — removing it would distort the study result, so consent documents generally set this out before you sign.
- You are a code, not a name — records held by the sponsor, the ethics committee and the regulator identify you by a participant number under confidentiality obligations.
- New collection stops when you say so — state whether you are withdrawing from treatment, from follow-up, or from both, so there is no ambiguity.
- Stored samples can often be destroyed — blood or tissue kept for future research can usually be withdrawn on request; a sample already used in a completed analysis cannot be recalled.
- Put the request in writing — a dated letter to the investigator, with a copy kept, prevents any dispute about what you asked for and when.
- You may ask what the study found — participants are entitled to be told the results in a form they can understand, including after withdrawing.
This page is information, not recruitment. Nothing here is an offer of a place on any study, no enrolment can be assured by anyone, and no benefit is claimed for any investigational treatment. If you are still weighing a study up rather than leaving one, the honest list of downsides is set out in Risks of Joining an Immunotherapy Trial.
CION does not provide CAR-T or other cell therapies. Where a CAR-T or cell-therapy study is what is being discussed, that is a referral to a centre that runs it, and anything written here is orientation only.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Have Your Options Read With You Before You Stop
A free consultation covers what withdrawing changes, what your standard treatment path looks like afterwards, and who needs to be told.
Step by step
How Do You Withdraw From a Clinical Trial?
Tell the principal investigator that you are withdrawing consent, and put it in writing. Say whether you are stopping the study drug, the follow-up, or both. Ask for the end-of-study safety check and for the next treatment plan in writing. Six steps, and none of them need permission.
-
Tell the principal investigator, not only the ward staff
The principal investigator is the doctor responsible for your participation. Say it to them directly, in clinic or by a dated letter, and ask for the withdrawal to be entered in the study file that day.
-
Put it in writing and keep a copy
A verbal withdrawal is valid, but a signed, dated note removes any later argument about when you stopped. One paragraph is enough. Keep a photograph of it on your phone.
-
Say how far you are withdrawing
Stopping the study drug and leaving safety follow-up are two separate decisions. State which you mean. Many people stop the treatment and stay in follow-up, because follow-up is what protects them.
-
Take the end-of-study safety visit before you go
Most protocols include a final assessment with bloods and a review. It exists to catch a side effect that has not declared itself yet, and it costs you one appointment. Take it.
-
Get the next treatment plan in writing before you stop
Ask your oncologist what standard treatment follows, when it starts and where it is given. A written, dated plan is what prevents a gap opening between the study and routine care.
-
Tell every doctor who treats you afterwards
If you received an immunotherapy drug on the study, immune-related side effects can appear weeks or months after the last dose. Any doctor seeing you later, including in an emergency, needs to know what you had and when it stopped.
Consent is a process rather than a signature, and withdrawing is part of that process. The sequence above is general and indicative, as of August 2026; the exact procedure for your study is written in your participant information sheet and consent document. If a study team is reluctant to record a withdrawal, the ethics committee contact printed on that document is the next call.
Before you decide
What Should You Ask Before You Decide to Stop?
Ask four things. What treatment follows if you stop. Whether the problem that is driving this can be managed instead. Whether a dose can be held rather than stopped. And what you would be giving up access to. Many withdrawals turn out to be a response to one fixable problem.
- Is this a hold or a stop? — protocols usually allow a dose to be delayed or reduced for toxicity. A hold is not withdrawal, and it may be all that is needed.
- Can the side effect be managed? — immune-related side effects are handled under a defined protocol, often with steroids and supportive care. Ask what is available before concluding it is unmanageable.
- What is the standard plan if I stop? — written, dated, with a named start point, so the alternative is a real plan and not an assumption.
- What would I be giving up access to? — for many Indian families a study is one of the few routes by which this class of treatment becomes reachable at all. Ask what other routes exist, including whether any named-patient or compassionate-use route applies in your situation.
- Was this risk explained at the start? — compare what is happening now against what the consent document said would happen. If the two do not match, that is a question for the investigator.
- Who else needs to be told? — your own oncologist, your family physician, and any hospital that might see you in an emergency.
The exit is worth understanding before you take the entrance. Most of the anxiety about being trapped comes from questions that were never asked at the consent stage. The list worth taking into that first meeting is in Questions to Ask Before Joining a Trial, and the downside picture is in Risks of Joining an Immunotherapy Trial.
If access, not the study itself, is the real issue, a trial is not the only route to an unapproved or unaffordable medicine in India. Compassionate Use and Named Patient Access explains what those routes are and what they require. Nothing on this page offers, assures or recruits for any of them.
Talk to a specialist
Leaving a Trial Should Be a Decision, Not a Drift
Bring the consent document and your last scan report. We will go through what stops, what continues, and what happens next.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Withdrawing From a Cancer Trial: Common Questions
Can I withdraw from a cancer clinical trial after I have started?
Yes. Taking part is voluntary from the first day to the last, and you may stop at any point. Consent is not a contract that commits you to finish the study. Under India's New Drugs and Clinical Trials Rules, 2019 and the ICMR National Ethical Guidelines, a participant may withdraw at any time without losing benefits they were otherwise entitled to, and the consent document you signed must say so in a language you understand. You do not need permission from the sponsor and you do not need to wait for a scheduled visit. Tell the principal investigator, put it in writing, and ask for the withdrawal to be recorded in the study file.
Will leaving a clinical trial affect my future cancer treatment?
It should not. The standard treatment your diagnosis calls for does not depend on staying in a study, and your own oncologist keeps treating you. Ethics guidance is explicit that withdrawal must not cost you care you were otherwise entitled to, and a study team that suggests otherwise is not following it. What does change is the schedule. Study visits, study bloods and protocol scans stop, and a routine plan takes their place. Ask for that plan in writing, with a start date, before you stop, so there is no gap between the two. What you cannot assume is a right to rejoin later or a place on a different study, because no enrolment can be assured by anyone.
What happens to my data and samples if I withdraw from a trial?
Information already collected is normally kept and analysed. Removing it would distort the result, and the consent document you signed usually states this in advance. You are identified in that record by a code rather than by name, and the sponsor, the ethics committee and the regulator hold the documents under confidentiality obligations. What you can control is what happens next. Say clearly that no further data should be collected, and ask what happens to stored blood or tissue. Samples kept for future research can often be destroyed on request, while a sample already used in a completed analysis cannot be recalled. Put the request in writing and keep a dated copy.
Do I have to give a reason for leaving a clinical trial?
No. You may withdraw for any reason or for none, and you are not obliged to explain yourself to the study team, the sponsor or anyone else. In practice, a short conversation is often worth having anyway. Many withdrawals are a response to one problem that has a smaller answer than leaving, such as a side effect that can be managed, a dose that can be held or delayed under the protocol, or travel and cost pressure that the study team may be able to reduce. Ask what the options are first. If the answer does not change your mind, withdraw, and no one is entitled to obstruct it.
Can the study doctor remove me from a trial without my agreement?
Yes, and this is normal rather than punitive. A protocol lists conditions under which the investigator must take a participant off study treatment, usually because continuing would be unsafe, because the disease has progressed, or because the eligibility criteria are no longer met. A sponsor, the ethics committee or the regulator can also stop a study for everyone. In each case the reason should be explained to you, an end-of-study safety assessment should be offered, and a standard treatment plan should be put in place. Ask for the reason in writing, and ask what treatment follows and when it begins.
Can I rejoin the trial later, and does CION enrol patients into trials?
Rejoining is generally not automatic. Once you have withdrawn, a return would need the protocol to permit it, the eligibility criteria to still be met and the study to still be open, so treat the decision as a real one rather than a pause. This page is information, not recruitment. Nothing on it is an offer of a place on any study, no enrolment can be assured by anyone, and no benefit is claimed here for any investigational treatment. CION Cancer Clinics administers approved immunotherapy as day care at its centres and coordinates response-assessment PET-CT at partner imaging centres rather than owning them. CION does not provide CAR-T or other cell therapies; where a cell-therapy study is under discussion, that is a referral to a centre that runs it.